Yanbin Wang
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Autophagy in Disease and Therapy 3
- Liver Disease Diagnosis and Treatment 3
- Hepatitis B Virus Studies 2
- Co-authors
- Jianyu Hao (3 shared papers)Ran Xue (3 shared papers)Jianxin Wang (2 shared papers)Minhua Chen (3 shared papers)Shanshan Yin (3 shared papers)Kai Jia (1 shared paper)Lingyun Gao (1 shared paper)Hao Wang (1 shared paper)
- Journals
- Tissue and Cell (2 papers)Oxidative Medicine and Cellular Longevity (2 papers)Clinical Cancer Research (1 paper)Infection and Drug Resistance (1 paper)Autonomic Neuroscience (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yanbin Wang
45 papers receiving 760 citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Hepatology 89
- Oncology 242
- Immunology 103
- Epidemiology 131
- Molecular Biology 258
Countries citing papers authored by Yanbin Wang
This map shows the geographic impact of Yanbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanbin Wang more than expected).
Fields of papers citing papers by Yanbin Wang
This network shows the impact of papers produced by Yanbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanbin Wang. The network helps show where Yanbin Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanbin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Hit paper breakdown → | 2021 | 202 |
| 2 | 2018 | 87 | |
| 3 | 2006 | 61 | |
| 4 | 2020 | 56 | |
| 5 | 2018 | 48 | |
| 6 | 2019 | 39 | |
| 7 | 2019 | 35 | |
| 8 | 2012 | 30 | |
| 9 | 2019 | 26 | |
| 10 | 2011 | 22 | |
| 11 | 2019 | 19 | |
| 12 | 2021 | 16 | |
| 13 | [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation]. | 2005 | 16 |
| 14 | 2019 | 15 | |
| 15 | 2022 | 12 | |
| 16 | 2016 | 9 | |
| 17 | 2020 | 8 | |
| 18 | 2022 | 7 | |
| 19 | 2024 | 6 | |
| 20 | 2015 | 6 |
About Yanbin Wang
Yanbin Wang is a scholar working on Molecular Biology, Epidemiology, Surgery, Pulmonary and Respiratory Medicine and Hepatology, having authored 49 papers that have together received 771 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Autophagy in Disease and Therapy (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Liver Disease and Transplantation (2 papers), Urinary Bladder and Prostate Research (2 papers), Hepatitis B Virus Studies (2 papers), Trauma Management and Diagnosis (2 papers) and Traumatic Brain Injury and Neurovascular Disturbances (2 papers). The work is most often cited by research in Hepatology (89 citations), Oncology (242 citations), Immunology (103 citations), Epidemiology (131 citations) and Molecular Biology (258 citations). Yanbin Wang has collaborated with scholars based in China and United States. Frequent co-authors include Jianyu Hao, Ran Xue, Jianxin Wang, Minhua Chen, Shanshan Yin, Kai Jia, Lingyun Gao, Hao Wang, Xiaohong He and Yi Chen. Their work appears in journals such as Tissue and Cell, Oxidative Medicine and Cellular Longevity, Clinical Cancer Research, Infection and Drug Resistance and Autonomic Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.